MENU
ARE
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION

ARE stock forecast, quote, news & analysis

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT)... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
A.I.Advisor
Nov 04, 2026

Alexandria Real Estate Equities (ARE) Stock Analysis: A High-Yield REIT's Rebound From a 52-Week Low

Key Takeaways

  • Alexandria Real Estate Equities shares are little changed over the trailing month, recently trading near $46 after a sharp late-October selloff and an equally sharp early-November rebound.
  • The stock touched a 52-week low of $38.34 on Oct. 28, 2026, before recovering more than 15% from its late-October closing low.
  • Third-quarter 2026 results disclosed sizable asset impairments that deepened GAAP losses, though management emphasized resilience in its core life science markets.
  • ARE carries a dividend yield of roughly 6.8% and trades well below book value, underscoring how far sentiment has reset across the life science real estate sector.
  • Analysts maintain a consensus "Hold" rating with an average price target near $50, below the stock's 52-week high of $59.76.
  • Interest rates, biotech funding, and leasing demand remain the dominant swing factors for the shares.
  • For more detail, explore Alexandria Real Estate Equities' Price Targets, Earnings, and Forecast on Tickeron.
  • Discover how AI-driven trading systems approach ARE and thousands of other tickers through Tickeron's Trending AI Robots.

Current Market Snapshot

Alexandria Real Estate Equities (ARE) is trading near $46, giving the company a market capitalization of roughly $7.4 billion. That places the stock in the lower portion of its 52-week range of $38.34 to $59.76, and below both its 50-day moving average near $47.6 and its 200-day moving average near $49.4. The shares continue to offer one of the higher dividend yields in the equity REIT space at approximately 6.8%, reflecting the market's cautious stance on life science real estate fundamentals.

The broader REIT complex has remained sensitive to the interest-rate environment, and life science landlords have faced an added layer of pressure from a prolonged slowdown in biotech venture funding. ARE's roughly 30-day round trip — from the mid-$40s down to a 52-week low and back — illustrates the elevated volatility that has accompanied shifting sentiment around lab-space demand.

Alexandria Real Estate Equities (ARE) Business Overview and Competitive Position

Founded in 1994 and headquartered in Pasadena, California, Alexandria Real Estate Equities is a mission-driven life science REIT and a pioneer of the life science real estate niche. The company owns, operates, and develops collaborative "megacampus" ecosystems in leading life science and advanced technology innovation clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.

Its portfolio is leased primarily to life science, agtech, and advanced technology tenants, with long-duration leases and mission-critical laboratory infrastructure that is costly and difficult to replicate. This concentration in top innovation hubs, combined with deep relationships across the pharmaceutical and biotech ecosystem, underpins the company's competitive position. Investors follow ARE both for its income profile and as a barometer of biotech funding, lab-space demand, and the health of the life science economy.

Recent Developments Driving ARE

The most significant recent catalyst was the company's third-quarter 2026 report, released in late October. The results disclosed larger-than-expected asset impairments that deepened the company's GAAP net loss and helped push the stock to a 52-week low of $38.34 on Oct. 28, 2026. On the accompanying earnings call, however, management struck a more measured tone, highlighting the resilience of its portfolio and leasing activity in core life science clusters.

That message helped spark a rebound, with the stock climbing back toward $46 by early November. The recovery also reflected a broader reassessment of valuation, as ARE trades near half of book value per share and carries a dividend that remains supported by the company's cash flow. Wall Street's stance has stayed cautious, with a consensus "Hold" rating and an average 12-month price target near $50, implying that analysts see limited near-term upside until leasing fundamentals show clearer signs of stabilization.

Trending AI Robots

Tickeron's Trending AI Robots page showcases a curated selection of the platform's most relevant and best-performing automated trading systems. Tickeron offers hundreds of AI trading bots that trade thousands of tickers, but only the top-performing and most timely robots are featured in this section. These bots vary widely in strategy, holding timeframe, and performance metrics, ranging from short-term momentum approaches to longer-horizon trend models. The section is designed to help traders quickly identify AI-driven systems that are currently demonstrating strength across the market. Investors monitoring names such as ARE may find it a useful way to observe how algorithmic strategies are positioning across the life science and REIT sectors.

2026 Outlook and What Investors Should Watch

Looking ahead, the primary macro variable remains the path of interest rates, which directly influences REIT valuations, cap rates, and financing costs. On the industry side, the trajectory of biotech venture funding and lab-space demand will be critical, as a sustained recovery in tenant demand would support occupancy, rental growth, and ultimately the company's funds from operations.

Investors should also monitor whether further impairment charges materialize, the status of development pipeline deliveries, and the company's progress on deleveraging. Dividend coverage will remain a focal point given the elevated yield, as will any shifts in analyst price targets following the next earnings report, expected in late January 2027. As always, these forward-looking considerations carry uncertainty and should be weighed alongside each investor's own research and risk tolerance.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

A.I.Advisor
a Summary for ARE with price predictions
Nov 13, 2026

ARE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ARE turned positive on November 02, 2026. Looking at past instances where ARE's MACD turned positive, the stock continued to rise in 24 of 34 cases over the following month. The odds of a continued upward trend are 71%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ARE's RSI Indicator exited the oversold zone, 23 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on ARE as a result. In 45 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 63%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 42 of 55 cases where ARE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.

The 50-day moving average for ARE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

ARE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ARE entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.538) is normal, around the industry mean (0.873). P/E Ratio (102.987) is within average values for comparable stocks, (201.021). Projected Growth (PEG Ratio) (0.280) is also within normal values, averaging (0.666). Dividend Yield (0.072) settles around the average of (0.163) among similar stocks. ARE's P/S Ratio (7.435) is very high in comparison to the industry average of (2.856).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. ARE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
published Dividends

ARE paid dividends on October 15, 2026

Alexandria Real Estate Equities ARE Stock Dividends
А quarterly dividend of $0.72 per share was paid with a record date of October 15, 2026, and an ex-dividend date of September 30, 2026. Read more...
A.I.Advisor
published Highlights

Market Cap

The average market capitalization across the REIT - Office Industry is 2.43B. The market cap for tickers in the group ranges from 6.34M to 9.97B. BXP holds the highest valuation in this group at 9.97B. The lowest valued company is CMCT at 6.34M.

High and low price notable news

The average weekly price growth across all stocks in the REIT - Office Industry was 1%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was 343%. CMCT experienced the highest price growth at 35%, while FSP experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the REIT - Office Industry was -42%. For the same stocks of the Industry, the average monthly volume growth was -42% and the average quarterly volume growth was -68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 64
Price Growth Rating: 51
SMR Rating: 89
Profit Risk Rating: 93
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a real estate investment trust

Industry REITOffice

Industry
Real Estate Investment Trusts
Address
26 North Euclid Avenue
Phone
+1 626 578-0777
Employees
514
Web
https://www.are.com